| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a260c51a9c8f1baea32edfe5a3d3ee27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94e448d4ce69c414a98df1dfdf1a3254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0368a4dd306afddc8557fce8a1e7d10b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fea7e877aa0b6feb43b57cc1782be2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fddb6e9577f91fc5df4eb24d59e4496 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
1993-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e58a08725053953c399199dcf8ddf37d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e11dc9049ab88f6313fc7fea3a96fbf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_992d55e66f436bade0b7614112c2e8d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc9c1abd80640f347009d54e673d534f |
| publicationDate |
1994-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9401464-A1 |
| titleOfInvention |
Leukaemia inhibitory factor-binding protein |
| abstract |
The present invention relates to an isolated leukaemia inhibitory factor (LIF)-binding protein (LBP) in soluble form and obtainable from a first mammalian species, said LBP capable of inhibiting the ability of LIF from a second mammalian species to induce differentiation of M1 myeloid leukaemic cells in vitro to a greater extent when compared to its ability to inhibit LIF from said first mammalian species. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5785967-A |
| priorityDate |
1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |